Perception of changes in marine benthic habitats: The relevance of taxonomic and ecological memory

Having a reliable ecological reference baseline is pivotal to understanding the current status of benthic assemblages. Ecological awareness of our perception of environmental changes could be better described based on historical data. Otherwise, we meet with the shifting baseline syndrome (SBS). Facing SBS harmful consequences on environmental and cultural heritage, as well as on conservation strategies, requires combining historical data with contemporary biomonitoring. In the present “era of biodiversity”, we advocate for (1) the crucial role of taxonomy as a study of life diversity and (2) the robust, informative value of museum collections as memories of past ecosystem conditions. This scenario requires taxonomist skills to understand community composition and diversity, as well as to determine ecosystem change trends and rates. In this paper, we focus on six Mediterranean benthic habitats to track biological and structural changes that have occurred in the last few decades. We highlight the perception of biological changes when historical records make possible effective comparisons between past reference situations and current data. We conclude that the better we know the past, the more we understand present (and will understand future) ecosystem functioning. Achieving this goal is intrinsically linked to investing in training new taxonomists who are able to assure intergeneration connectivity to transmit cultural and environmental heritage, a key aspect to understanding and managing our changing ecosystems

Effects of Bulk Viscosity in Non-linear Bubble Dynamics

The non-linear bubble dynamics equations in a compressible liquid have been modified considering the effects of compressibility of both the liquid and the gas at the bubble interface. A new bubble boundary equation has been derived, which includes a new term resulted from the liquid bulk viscosity effects. The influence of this term has been numerically investigated considering the effects of water vapor and chemical reactions on the bubble evolution. The results clearly indicate that the new term has an important damping role at the collapse, so that its consideration decreases the amplitude of the bubble rebounds after the collapse. This damping feature is more remarkable for higher deriving pressures.Comment: 4 pages, 7 figure

Evaluation of the dual mTOR / PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models

We are grateful to Wyeth/Pfizer (ONC-EU-150) and to the Scottish Funding Council (SRDG HR07005) for support of this study.This study investigated the antitumour effects of two dual mTOR/PI3K inhibitors, gedatolisib (WYE-129587/PKI-587/PF-05212384) and PF-04691502 against a panel of six human patient derived ovarian cancer xenograft models. Both dual mTOR/PI3K inhibitors demonstrated antitumour activity against all xenografts tested. The compounds produced tumour stasis during the treatment period and upon cessation of treatment, tumours re-grew. In several models, there was an initial rapid reduction of tumour volume over the first week of treatment before tumour stasis. No toxicity was observed during treatment. Biomarker studies were conducted in two xenograft models; phospho-S6 (Ser235/236) expression (as a readout of mTOR activity) was reduced over the treatment period in the responding xenograft but expression increased to control (no treatment) levels on cessation of treatment. Phospho-AKT (Ser473) expression (as a readout of PI3K) was inhibited by both drugs but less markedly so than phospho-S6 expression. Initial tumour volume reduction on treatment and regrowth rate after treatment cessation was associated with phospho-S6/total S6 expression ratio. Both drugs produced apoptosis but minimally influenced markers of proliferation (Ki67, phospho-histone H3). These results indicate that mTOR/PI3K inhibition can produce broad spectrum tumour growth stasis in ovarian cancer xenograft models during continuous chronic treatment and this is associated with apoptosis.Publisher PDFPeer reviewe

EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence

<p>Abstract</p> <p>Background</p> <p>Ameloblastoma is an odontogenic neoplasm characterized by local invasiveness and tendency towards recurrence.</p> <p>Aims</p> <p>Studying the role played by EGFR, CD10 and Ki67 in the recurrence of ameloblastoma.</p> <p>Methods</p> <p>This study was carried out on 22 retrospective cases of mandibular ameloblastoma from the period from Jan 2002 to Jan 2008 with follow up period until Jan 2011 (3 to 8 years follow up peroid). Archival materials were obtained from pathology department, Mansoura university. Paraffin sections of tumor tissue from all cases were submitted for routine H&E stains and immunohistochemistry using EGFR, CD10 and Ki67 monoclonal antibodies. Statistical analysis using of clinical data for all patients, tumor type, EGFR, CD10 and Ki67 expression in relation to recurrence were evaluated.</p> <p>Results</p> <p>Among the 22 cases, 10 cases were males and 12 were females with sex ratio 1:1.2. Age ranged from 34 to 59 years old with a mean age 44.18 year. Five cases showed local recurrence within studied period and proved by biopsy. No statistically significant relation was found between local recurrence and patient age, tumor size, tumor type, EGFR expression. There was a significant relation between CD10 expression as well as Ki67 labelling index and recurrence (P value = 0.003, 0.000 respectively).</p> <p>Conclusion</p> <p>Evaluation of CD10 and Ki67 status together with conventional histological evaluation can help in providing more information about the biologic behavior of the tumor, while EGFR could be a target of an expanding class of anticancer therapies.</p> <p>Since ameloblastomas are EGFR-positive tumors, anti-EGFR agents could be considered to reduce the size of large tumors and to treat unresectable tumors that are in close proximity to vital structures.</p> <p>Virtual Slides</p> <p>The virtual slide(s) for this article can be found here:</p> <p><url>http://www.diagnosticpathology.diagnomx.eu/vs/1902106905645651</url></p

Mysid crustaceans as standard models for the screening and testing of endocrine-disrupting chemicals

Author Posting. © Springer, 2007. This is the author's version of the work. It is posted here by permission of Springer for personal use, not for redistribution. The definitive version was published in Ecotoxicology 16 (2007): 205-219, doi:10.1007/s10646-006-0122-0.Investigative efforts into the potential endocrine-disrupting effects of chemicals have mainly concentrated on vertebrates, with significantly less attention paid to understanding potential endocrine disruption in the invertebrates. Given that invertebrates account for at least 95% of all known animal species and are critical to ecosystem structure and function, it remains essential to close this gap in knowledge and research. The lack of progress regarding endocrine disruption in invertebrates is still largely due to: (1) our ignorance of mode-of-action, physiological control, and hormone structure and function in invertebrates; (2) lack of a standardized invertebrate assay; (3) the irrelevance to most invertebrates of the proposed activity-based biological indicators for endocrine disruptor exposure (androgen, estrogen and thyroid); (4) limited field studies. Past and ongoing research efforts using the standard invertebrate toxicity test model, the mysid shrimp, have aimed at addressing some of these issues. The present review serves as an update to a previous publication on the use of mysid shrimp for the evaluation of endocrine disruptors (Verslycke et al., 2004a). It summarizes recent investigative efforts that have significantly advanced our understanding of invertebrate-specific endocrine toxicity, population modeling, field studies, and transgeneration standard test development using the mysid model.Supported by a Fellowship of the Belgian American Educational Foundation

The ecdysone receptor puzzle

Abstract: The present article reviews some recent findings on the functional ecdysone † receptor which is a heterodimer of two proteins: ecdysone receptor (EcR) and Ultraspiracle (USP). Emphasis is given to some unique aspects of this receptor, in particular to its dimerization, binding to DNA, and transactivation capabilities. The effects of ligands (ecdysone, juvenile hormone) on these functions are discussed. In addition, perspectives on future work on this receptor are outlined, which are shaped by recent progress in the nuclear receptor field in general. This preview part of the present article concerns mainly the 3-D structure of receptor domains, the formation of large supramolecular receptor complexes, their influence on chromatin remodelling, receptor phosphorylation, as well as inter-and intramolecular cross-talks of receptor domains. Keywords: ecdysone receptor; Ultraspiracle; receptor dim erization; juvenile hormone; transactivation Abbreviations Used: Ec = ecdysone; EcR = ecdysone receptor; EcRE = ecdysone response element; JH = juvenile hormone; RAR = retinoic acid receptor; RXR = retionid X receptor; USP = ultraspiracle. Abstract: INTRODUCTION The present short review and preview article deals with that type of ecdysone † (Ec) receptor that is composed of the two proteins called EcR and USP (for -Ec receptor‖ and -Ultra spiracle,‖ respectively) and whose principal site of action is the genome. This does not exclude other putative sites of action for this receptor nor does it rule out the likely existence of other Ec receptor type